Tulaven®

Product information

Easy to administrate (one shot): Its concentration dedicated exclusively to swine (25 mg/ml)
facilitate optimal administration in farrowing and weaning piglets with only one shot.

• Optimal and Confident administration (peace of mind)
• Reduced financial risk

Safe and high effective: Tulathromycin has unique effect due to its rapid and extensive
distribution into the lung tissue (target tissue of respiratory pathogens). Very long duration and
potential effect can be estimated based on plasma/lung ratio of tulathromycin in lungs. At 408 h
(17 days) post-tulathromycin administration, the lung/plasma ratio was >300 for both lung lobes
during the Pk/Pd study.
Tulathromycin provides at least 9 days of complete protection against A. pleuropneumoniae
during the challenge trial. Duration of treatment effect for 15 days was observed based on clinical
symptoms and examination of bronchoalveolar lavage (BAL) for H. parasuis and P. multocida.
Tulathromycin provide 14 days clinical effect for SRD associated with B. bronchiseptica based on
Day 14 clinical cure rate. Treatment effect of tulathromycin for minimally 13 days was established
following experimental infection of swine with Mycoplasma hyopneumoniae. Due to the very
low and stable MIC90 for M. hyo strains and Tulathromycin relatively high concentration in lungs
we can assume even longer effect.